The 2 1 integrin serves as a receptor for collagens, laminin, and/or several other nonmatrix ligands. Many studies have suggested that the 2 1 integrin is a critical mediator of platelet adhesion to collagen within the vessel wall after vascular injury and that the interactions of the platelet 2 1 integrin with subendothelial collagen after vascular injury are required for proper hemostasis.
Introduction
The 2 1 integrin serves as a receptor for collagens, laminin, and several other nonmatrix ligands [1] [2] [3] . The integrin has been extensively studied as a collagen receptor on platelets [4] [5] [6] [7] . Many studies have suggested that the 2 1 integrin is a critical mediator of platelet adhesion to collagen within the vessel wall after vascular injury and that the interactions of the platelet 2 1 integrin with subendothelial collagen after vascular injury are required for proper hemostasis.
Collagen not only serves as an adhesive substrate, but in its fibrillar form also For personal use only. on September 14, 2017 . by guest www.bloodjournal.org From activates platelets leading to secretion of granule contents and platelet aggregation 4 . The relative roles of the 2 1 integrin and the GPVI/ F c receptor (F c R ) chain complex, another platelet collagen receptor, in platelet adhesion, platelet activation and aggregation have been intensely debated [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] .
Experimental evidence documenting a role for the platelet 2 1 integrin in thrombus formation in vivo has been lacking.
The extent of 2 1 expression varies greatly among individuals and is determined by several linked polymorphisms within the 2 integrin subunit gene [20] [21] [22] . A potentially important role for the 2 1 integrin is suggested by recent epidemiologic data. Some data reveal a direct correlation between the genetically determined surface density of platelet 2 1 integrin expression and the risk of thrombotic events. High level 2 1 integrin expression on platelets is an independent risk factor for non-fatal myocardial infarction in individuals less than 62 years of age, for the development of diabetic retinopathy in patients with Type II diabetes mellitus, and for stroke in the young [23] [24] [25] [26] [27] [28] . However, other studies failed to find a correlation between the level of 2 1 integrin expression and the risk of thrombotic events. The mechanistic relationship inferred between the level of 2 1 integrin expression and the development of vascular disease require experimental evaluation in vivo using animal models.
To better define the role of the 2 1 integrin in vivo, we have recently developed a genetically engineered mouse in which expression of the 2 1 integrin has been completely eliminated 29 . Mice deficient in the 2 
Methods

Mice
The development of mice with complete genetic deletion of the 2 integrin subunit gene was previously described 29 . Wild-type ( 2 +/+), heterozygous ( 2 +/-), and 2 -deficient ( 2 -/-) mice were descendants of F2 intercrosses and were on a mixed C57Bl/6-129SvJ background. On average, the mice contained approximately 50% C57Bl/6 and 50% 129SvJ alleles. Heterozygous breeding pairs produced littermates that were wild-type, heterozygous, or 2 -deficient.
Littermate controls were used in all experiments. The FcR chain-deficient mice on a mixed C57Bl/6-129SvJ background were a generous gift from Dr. Paul Allen of Washington University School of Medicine. Mice were weaned to a rodent diet at 21 days of age and used for experiments when 10-15 weeks of age.
Blood collection and blood counts
Mice were anesthetized with a ketamine and xylazine mixture, and blood was collected by puncture of the retroorbital plexus with a Pasteur pipette and placed into EDTA-coated microtainer tubes. Blood was analyzed for platelet count and hematocrit using a Mascot Hemavet 850 analyzer (CDC Technologies, Oxford, CT) set to a mouse cell program. 
Arterial thrombosis model
Carotid artery thrombosis was induced as described previously 30 . Briefly, male mice approximately 12 weeks of age were anesthetized with intraperitoneal sodium pentobarbital, secured in the supine position, and placed under a dissecting microscope. The right common carotid artery was isolated through a midline cervical incision, and an ultrasonic flow probe (Model 0.5 VB, Transonic Systems, Ithaca, NY) was applied. A 1.5-mW, 540 nm laser beam (Melles Griot, Carlsbad, CA) was applied to the artery from a distance of 6 cm. Rose bengal dye (Fisher Scientific, Fair Lawn, NJ) 50 mg/kg body weight was then injected into the tail vein, and flow in the vessel was monitored until complete occlusion occurred.
Collagen-Induced Thrombosis
Studies of collagen-induced thrombosis were carried out as described by Smythe et al 31 . Wild-type, 2 1 integrin-deficient , and FcR -deficient female mice were anesthetized by intraperitoneal injection of 100-150 µl of a mixture of ketamine and xylazine. Blood was collected into EDTA-coated microtainer tubes for determination of the baseline platelet count and hematocrit. Various amounts (25, 12, 6 and 3 µg) of collagen (equine tendon type I fibrillar collagen; Chronolog) plus 1 µg epinephrine (Sigma) in PBS, or PBS alone, were injected into the right jugular vein; one minute after injection a second blood sample was taken. Mice were euthanized three minutes after injection and lungs were collected and placed in formalin.
Quantitation of Pulmonary Thrombosis
Hematoxylin and eosin stained sections of the lungs were digitally imaged using an Olympus Camedia C-3040 Zoom camera. Five random 20X fields were photographed for each specimen. Analysis of thrombus number for each mouse was made using the Olympus Camedia Master 2.5 software, and then expressed as thrombi per mm 2 +/ -SEM.
Statistical analysis
Statistical significance was determined with the Student 2-tailed t-test (http://faculty.vassar.edu/lowry/VassarStats.html). A P value <0.05 was considered significant.
Histology
Tissues examined by light microscopy, including carotid artery segments and lungs were fixed in 10% formalin and paraffin-embedded. Sections (4µM)
were stained with Harris' hematoxylin and eosin.
Results
Carotid Artery Thrombosis
To determine the importance of the 2 Carotid arteries obtained immediately following complete occlusion were evaluated morphologically on routine hematoxylin and eosin-stained sections.
As expected, the thrombi consisted of a mixture of platelets and fibrin ( Figure   1C ). There was no obvious histologic difference between the thrombi found in wild-type and 2 -deficient mice. The number of thrombi in the lungs at the time of sacrifice 3 minutes after the injection was also quantitated, as shown in Figure 2B and 2C. Consistent with the decrements in platelet count, the numbers of intravascular thrombi in the Figure 2B and 2C). No thrombi were observed in the lungs of control mice injected with saline alone. Therefore, the presence of the 2 1 integrin is not required for formation of pulmonary emboli induced by intravascular injection of a high concentration of collagen (i.e., 25 µg).
Figure 1A
We previously reported that platelets from 2 -null animals aggregated in response to high concentrations of Type I collagen in a manner similar to platelets from wild-type litter mates 29 . In contrast, platelets from 2 -null animals aggregated with a significantly prolonged lag phase and a decreased rate of platelet aggregation in response to low concentrations of collagen It has been previously reported that mice deficient in the GPVI/ F c R complex are protected from the formation of thrombi and pulmonary emboli following intravenous injection of fibrillar collagen 32 . As a control for the negative findings regarding the role of the 2 1 integrin, we therefore examined the effect of 
Discussion
Collagen serves as an adhesive substrate and in its fibrillar form activates platelets leading to secretion of granule contents and platelet aggregation [4] [5] [6] [7] . A number of studies have suggested that the 2 1 integrin is a critical mediator of platelet adhesion to subendothelial collagen and is required for effective hemostasis. The relative roles that the 2 1 integrin and the GPVI/F c R complex play in mediating platelet adhesion and subsequent platelet activation, aggregation and thrombus formation have been intensively debated [4] [5] [6] [7] 33 . The sometimes conflicting results from various in vitro or ex vivo experimental systems that may differentially reflect the relative contributions of the two receptors have perhaps contributed to the confusion.
In the original version of the two-step, two-site model of collagen-induced platelet adhesion and activation, it was proposed that the 2 1 integrin supported the initial adhesion of platelets to vessel wall collagen 11 . In a second step, a low-affinity signal transducing co-receptor for collagen, most likely glycoprotein VI (GpVI), was subsequently engaged and mediated platelet activation and
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From aggregation [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Thus, the 2 1 integrin was thought to play a major role in adhesion, but was thought not to contribute signals to platelet activation or aggregation.
12,13 More recent findings suggest that both the 2 1 integrin and GPVI may contribute to the overall process of platelet adhesion, activation and aggregation, and that the relationship between the two receptors and their relative contributions may be more complex than initially envisioned 18 .
Furthermore, tethering of platelets to exposed subendothelium via a von
Willebrand factor (VWF)-glycoprotein Ib interaction precedes engagement of either of the two collagen receptors. Under some conditions tethering by VWF may be sufficient for a limited initiation of signaling through the GpVI complex.
The recent development of mice deficient in all 1 integrins or selectively deficient in the 2 1 integrin, GPVI or the F c R has provided unique and valuable tools to definitively characterize the independent and cooperative roles of the 2 1 integrin and the GPVI/ F c R complex in platelet biology and to address key unresolved issues regarding the role of the two receptors in platelet adhesion, activation, signaling and vascular pathobiology [15] [16] [17] [18] 32, [34] [35] [36] [37] . The 2 -deficient mice have no obvious bleeding tendency 16, 29 . Using washed platelets purified from 2 -deficient mice, we previously reported that the 2 1 integrin is required for platelet adhesion to collagen under both static and flow conditions. Prolongation of the lag phase of collagen-induced platelet aggregation was observed only at low concentrations of collagen 29 .
Our results differed in some ways from those of Holtkotter et al. 16 . Since their initial in vitro studies of platelet adhesion and aggregation using 2 [21] [22] [23] [24] [25] [26] [27] [28] . Based on some epidemiologic data, we expected to observe a gene dosage effect in mice heterozygous for 2 1 integrin deficiency. However, no gene dosage effect in the carotid injury model was observed. Only homozygous deficient animals were protected. These results are in line with the studies of Moshfegh et al. They reported that homozygosity, but not heterozygosity, for the 807T/873A genotype was an independent risk factor for acute myocardial infarction 27 . Our findings suggest that if pharmacologic inhibition of the 2 1 integrin is to be exploited clinically, a high degree of inhibition will be required for efficacy.
In contrast to the important role that the integrin plays in platelet adhesion and thrombus formation at the blood-vessel wall interface under flow conditions, the integrin does not appear to play a role in a model of pulmonary embolism following the intravascular injection of collagen to initiate thrombus formation. In summary, the studies described in this report reveal distinctly different roles for the 2 
